Introduction
Peripheral intrathoracic lesions have broad differential diagnosis including malignant, benign, and inflammatory lesions. These lesions can be in the parenchyma, either pleural or mediastinal. Tissue diagnosis is the gold standard for these lesions, obtained either by open lung biopsy, mediastinoscopy, or video-assisted thoracic surgery. Image-guided percutaneous transthoracic biopsy has become a widely accepted, effective, and safe minimally invasive technique to obtain tissue specimens [1] [2] [3] .
Previous studies [4, 5] have compared ultrasound (US)guided and computed tomography (CT)-guided biopsy from pleural and peripheral lung lesions done only by a radiologist and the role of US is emerging in the treatment of pulmonary diseases and now it is being used in the assessment of various pulmonary diseases with real-time guidance, free of ionizing radiation. In addition, US equipment is less expensive than CT machines and is generally more widely available. Portable US machines can also be moved to the patient's bedside. US-guided transthoracic biopsy has become a valuable tool for pulmonologists.
In this study, we compared the diagnostic yield and complications of US-guided transthoracic biopsy and CT-guided biopsy in peripheral intrathoracic lesions with cooperation of the Chest and Radiology Departments, Menoufia University Hospital. It is the first time to be compared in our hospital and the also the first time for pulmonologists in our hospital to do US-guided transthoracic biopsy.
Patients and methods
This observational cohort study was carried out in the Chest and Radiology Departments, Menoufia University Hospital in the period between January 2017 and January 2019 on 100 patients with undiagnosed peripheral intrathoracic lesions who were divided into two groups. Group I included 50 patients with peripheral intrathoracic lesions on whom transthoracic core-needle biopsy (CNB) was carried out guided by US. Group II included 50 patients with peripheral intrathoracic lesions on whom CNB was carried out guided by chest CT.
In group I, the ages ranged between 23 and 72 years with a mean of 58.1±10.0 years, while in group II the age ranged between 30 and 72 years with a mean of 57.5±10.1 years. Group I included 35 men and 15 women, while group II included 34 men and 16 women. In group I, 64% patients were smokers, while in group II 56% patients were smokers.
We excluded from the study patients with intrathoracic lesions away from the chest wall by more than 2 cm, patients with bleeding diathesis (international normalized ratio of>1.3 or platelet count of<100 000/mm 3 ), hemodynamic instability, cardiovascular instability, for example, unstable angina, recent myocardial infarction, or uncontrolled severe hypertension, severe chronic obstructive pulmonary disease forced expiratory volume 1 (FEV 1 <1 l or <35% predicted), hypervascular lesion or aneurysm, patient on positive pressure ventilation, severely limited function of contralateral lung or contralateral pneumonectomy and suspicion of hydatid cyst.
This study was approved by the Research Ethics Committee, Faculty of Medicine, Menoufia University and an informed written consent was taken from each. The procedure was done while the patients were placed supine, prone or lateral decubitus, according to the position which gave greater access with the best safety profile. After localization of the most accessible site to perform biopsy, the skin was scrubbed with iodopovidone 2% and local anesthesia was used in every case using local subcutaneous injection of 10-20 ml lidocaine 2%. A snipe was done by scalpel no. 11. The patients were instructed to avoid deep breaths and coughing during the biopsy procedure.
Transthoracic CNB was carried out guided by US in group I. The affected region was scanned using US (EUB-7000; Hitachi, Japan) with a 3.5-MHz convex probe parallel to the ribs in the intercostal spaces. The biopsy was performed by using semiautomated springloaded tru-cut needle GTA [Quistello (MN), Italy] having a size of 18-G needle and a length of 10, 15, or 20 mm was chosen according to the size and distance of the lesion. The samples were sent for histopathological examination and diagnosis.
Transthoracic CNB was carried out guided by chest CT in group II using a CT scanner (Alexion, 16 detectors; Toshiba, Japan). The slice thickness should be less than half the diameter of the targeted lesion to be certain that a single CT image contains the lesion. With the use of the gantry laser light to delineate the Z-axis position, and radiopaque skin marker to determine the X-axis position, the needle entry site was marked on the patient's skin. The same CBNs (GTA) were used. Anew axial slices were made to confirm the correct location. The samples were sent for histopathological examination and diagnosis.
Chest radiograph was performed after 30 min and after 3 h to rule out any complications including pneumothorax, hemothorax, and soft tissue hematoma. The patient is observed for 6 h and then discharged.
Results
This study was carried out on 100 patients with undiagnosed peripheral intrathoracic lesions to reach final diagnosis.
In group I, US-guided transthoracic biopsy could diagnose all pleural lesions 100% (4/4) and 94.8% (37/39) of parenchymal lesions, and 80% (4/5) of mediastinal lesions, while in group II CT-guided transthoracic biopsy could diagnose all pleural lesions, 100% (6/6), all parenchymal lesions, 100% (42/42), and 75% (3/4) of mediastinal lesions ( Table 1 ).
The sensitivity of US-guided transthoracic biopsy in the diagnosis of peripheral intrathoracic lesions was 94%, while the sensitivity of CT-guided transthoracic biopsy was 98% ( Table 2) . (Table 3 and Figures 1 and 2) .
On comparing the complications of biopsy between the two studied groups it has been found that in group I there were no complications, while in group II pneumothorax was detected in one (2%) patient; perilesional contusion was detected in one (2%) patient and hemoptysis was detected in one (2%) patient (Table 4 ).
Discussion
Transthoracic US has become an important diagnostic tool in peripheral intrathoracic lesions. Transthoracic US needle biopsy is a safe and effective procedure under real-time US guidance, and may provide adequate tissue sampling of lesions for histological analysis. However, there are some limiting factors for US evaluation of the chest. First, air limits the progression of the sound waves. Second, the bones of the thorax absorb the sound waves, preventing propagation to the underlying tissues and thus limiting the US window. Third, it depends on operator skill. Fourth, the necessity to have a chest wall contact in order to completely analyze a lesion or to perform US guided biopsy. Therefore, only lesions with a good acoustic window can be sampled using this technique [6, 7] .
In this study, we compared the diagnostic yield of transthoracic US-guided core biopsy with CTguided core biopsy in diagnosing peripheral intrathoracic lesions. This study included patients with undiagnosed peripheral intrathoracic lesions with chest wall contact in group I, while group II included lesions with chest wall contact or away from chest wall by less than 2 cm. Other researches as done by Yaser and Ahmad [5] who compared the outcome of CT and US guidance when sampling peripheral lung or pleural lesions they included lesions with pleural origin or were peripherally located in the lung with a small amount of pleural contact.
In this study, we found that punctures for one or two times were sufficient and significantly increase the diagnostic yield in either US-guided or CT-guided CNB, one good puncture may be sufficient. This can be explained by the large mass lesions in this study as the mean diameter of lesions was 6.92 cm in group I and 4.41 cm in group II and the used 18-G needle that was sufficient for providing the final diagnosis. Also Morvay et al. [8] found that one good sample was sufficient for an exact final diagnosis and documented that in their study in 43 of the 45 cases, an exact histologic diagnosis could be provided. But Cao et al. [9] in their study of USguided transthoracic biopsy of peripheral lung and mediastinal lesions reported that performing repeated biopsies improved biopsy results.
As regards the needle used, the biopsy was performed by using semiautomated, spring-loaded tru-cut needle having a size of 18-G, a length of 10, 15, or 20 mm was chosen according to the size and distance of the lesion. We found that it was good in the diagnosis and does not increase the rate of pneumothorax. This can be explained that real-time monitoring helped avoid puncturing the aerated lung and the fact that all lesions were located peripherally. Also, Liao et al. [10] in their study of US diagnosis of chest diseases reported that transthoracic cutting biopsy with a large bore needle (18 G) does not increase the rate of pneumothorax, even for small pulmonary lesions less than 3 cm. But Geraghty et al. [11] in their study done on 846 CT-guided lung biopsies found that a smaller needle substantially decreases the risk of pneumothorax with comparable diagnostic sensitivity for histopathologic diagnosis of pulmonary nodules.
In this study, US guidance allowed for shorter procedure time than CT-guided procedures, as needle placement and biopsy can be performed during one breath hold, together with reducing patient discomfort, this decreases the time the needle is placed across the pleura. Also Blank [12] studied interventional chest sonography and reported that speed is the true advantage of the US-guided approach to transthoracic biopsy.
We found that the limitation to this study is the absence of a pathologist capable of making an onthe-spot pathology assessment of the lesion during the biopsy procedure. This would have reduced the number of lesions classified as necrotic. We recommend that a pathologist should be present during the procedure to increase the diagnostic yield.
In group I (US-guided core biopsy), there were six pleural cases, 39 peripheral parenchymal cases, and five mediastinal cases, whereas in group II (CT-guided core biopsy) there were four pleural cases, 42 peripheral pulmonary cases, and four mediastinal cases.
This study reported a diagnostic yield of 100% of USguided core biopsies in pleural lesions and their histopathology was pleural fibroma in two (4%) patients and mesothelioma in four (8%) patients and also with a diagnostic yield of 100% of CT-guided core biopsy in pleural lesions [mesothelioma in four (8%) patients].This result was in accordance with Diacon et al. [13] who studied the safety and yield of USassisted transthoracic biopsy performed by pulmonologists who showed that the success rate was 100% for malignant mesothelioma.
When the diagnostic yield of US-guided biopsy was compared with CT-guided biopsy of peripheral parenchymal lesions, this study showed a diagnostic yield of 94.8% of US as guidance for core biopsies in peripheral parenchymal lesions [inflammatory in two (4%) patients, adenocarcinoma in 21 (42%) patients, large-cell lung cancer in two (4%) patients, small-cell lung cancer in eight (16%) patients, squamous cell carcinoma in two (4%) patients, undifferentiated malignant neoplasm in two (4%) patients, and undiagnosed in two (4%) patients]. The diagnostic yield of 100% of CT-guided parenchymal biopsy was inflammatory in one (2%) patient, adenocarcinoma in 23 (46%) patients, large-cell lung cancer in one (2%) patient, small-cell lung cancer in 11 (22%) patients, squamous cell carcinoma in four (8%) patients, and undifferentiated malignant neoplasm in two (4%) patients. This result is consistent with Sperandeo et al. [14] who found that US-assisted CNB had a sensitivity of ∼85%, up to 97% for lung tumors abutting the chest wall during his study of the role of thoracic US in the assessment of pleural and pulmonary diseases. Also, Blank [12] who studied interventional chest sonography reported that the diagnostic yield of US that exceeds 90% is similar to that with the other imaging techniques.
These results showed a diagnostic yield (80%) of USguided core biopsies in mediastinal lesions: lymphoma in two (4%) patients, malignant thymoma in two (4%) patients, and undiagnosed in one (2%) patient. The diagnostic yield of CT-guided mediastinal biopsy in this study showed a diagnostic yield of 75%.
[lymphoma in two (4%) patients, malignant thymoma in one (2%) patient, and undiagnosed in one (2%) patient]. This result is in accordance with Liao et al. [10] who studied the US diagnosis of chest diseases which documented that US is as effective as CT for guidance of transthoracic biopsies of mediastinal tumors and offers a number of advantages. Real-time US imaging allows for dynamic evaluation of vessels and localization of target lesions that move during respiration.The sensitivity of US-guided transthoracic biopsy in the diagnosis of peripheral intrathoracic lesions was 94%, while the sensitivity of CT-guided transthoracic biopsy was 98%. There was no statistically significant difference between the studied groups as regards the sensitivity. This result was consistent with that by Sconfienza et al. [4] who compared the outcome of CT and US guidance when sampling peripheral lung or pleural lesions.
In this study, the procedure was generally well tolerated by the patients with no major complications recorded. In group I there was no complications, while in group II pneumothorax was detected in one (2%) patient, perilesional contusion was detected in one (2%) patient, and hemoptysis was detected in one (2%) patient. These results agree with other studies as Wiener et al. [15] and Rizzo et al. [16] who reported that pneumothorax incidence in patients when guided by US is less than when guided by CT scan.
Conclusion
US-guided transthoracic biopsy is a safe and effective method in the diagnosis of peripheral intrathoracic lesions as CT-guided transthoracic biopsy and offers numerous advantages such as accessibility (including bedside examinations), real-time monitoring, lower costs, no radiation exposure, and shorter biopsy time with fewer complications.
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